A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE WITH INSULIN IN PATIENTS WITH TYPE 2 DIABETES ADDING MEALTIME INSULIN TO A BASAL REGIMEN

被引：0
|
作者：
Kalsekar, A. [1 ]
Bonafede, M. M. [2 ]
Pawaskar, M. D. [1 ]
McGuffie, K. [3 ]
Torres, A.
Kelly, K. R. [1 ]
Curkendall, S.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Thomson Reuters, Cambridge, MA USA
[3] Thomson Reuters, Washington, DC USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75042-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A413 / A413
页数：1
相关论文
共 50 条
  • [21] Insulin deglucec, a new generation ultra-long acting insulin, in a mealtime plus basal regimen in people with type 1 diabetes: comparison to insulin glargine
    Meneghini, L.
    Home, E.
    DeVries, J. H.
    Jendle, J.
    Endahl, L.
    Lyby, K.
    Johansen, T.
    Roberts, A.
    Ratner, R.
    Wendisch, U.
    Birkeland, K. I.
    DIABETOLOGIA, 2010, 53
  • [22] A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients
    Pala, L.
    Mannucci, E.
    Dicembrini, I.
    Rotella, C. M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (01) : 132 - 135
  • [23] Gradual intensification of premixed insulin lispro therapy vs basal ± mealtime insulin in patients with type 2 diabetes eating light breakfasts
    Giugliano, D.
    Woo, V.
    Shah, S.
    Tracz, M.
    Mistodie, C.
    Calle-Pascual, A.
    Duarte, R.
    Sari, R.
    Deinhard, J.
    Jiletcovici, A. O.
    Wille, S.
    Kiljanski, J.
    DIABETOLOGIA, 2012, 55 : S386 - S386
  • [24] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
    Dailey, George
    Lin, Jay
    Wang, Edward
    DIABETES, 2012, 61 : A284 - A284
  • [25] Beginning a Basal plus Mealtime Insulin Regimen Using Prandial Insulin Aspart in Insulin-Naive Adults With Type 2 Diabetes: Results from the A1chieve Study
    Haddad, Jihad
    Litwak, Leon E.
    Malek, Rachid
    Zilov, Alexey V.
    Chakkarwar, Praful N.
    Khamseh, Mohammad E.
    DIABETES, 2012, 61 : A302 - A302
  • [26] Basal insulin requirement in insulin treated patients with type 2 diabetes mellitus
    Wiesli, P
    Lehmann, R
    Kraydenbühl, PA
    Schmid, C
    Spinas, GA
    DIABETES, 2005, 54 : A102 - A102
  • [27] ADDING INSULIN GLARGINE TO ORAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES RESULTS IN LONGER PERSISTENCE WITH TREATMENT COMPARED TO NPH INSULIN
    Pfohl, M.
    Dippel, F. W.
    Kostev, K.
    Kotowa, W.
    VALUE IN HEALTH, 2008, 11 (06) : A509 - A510
  • [28] Pramlintide improved glycemic control and reduced body weight in patients with type 2 diabetes treated with basal insulin (without mealtime insulin) and a thiazolidinedione
    Lorenzi, Gayle
    Frias, Juan
    Lutz, Karen
    Kesty, Nicole
    Zhang, Bei
    Kolterman, Orville
    DIABETES, 2007, 56 : A147 - A147
  • [29] Initiation and Gradual Intensification of Premixed Insulin Lispro Therapy Versus Basal ± Mealtime Insulin in Patients With Type 2 Diabetes Eating Light Breakfasts
    Giugliano, Dario
    Tracz, Mariusz
    Shah, Sanjiv
    Calle-Pascual, Alfonso
    Mistodie, Cristina
    Duarte, Rui
    Sari, Ramazan
    Woo, Vincent
    Jiletcovici, Alina O.
    Deinhard, Juergen
    Wille, Simone A.
    Kiljanski, Jacek
    DIABETES CARE, 2014, 37 (02) : 372 - 380
  • [30] INVESTIGATIONAL NEW INSULIN GLARGINE U300: GLYCAEMIC CONTROL AND HYPOGLYCAEMIA IN TYPE 2 DIABETES USING A MEALTIME plus BASAL INSULIN REGIMEN (EDITION I)
    Bolli, G. B.
    Home, P. D.
    Ziemen, M.
    Muehlen-Bartmer, I.
    Bizet, F.
    Riddle, M. C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A89 - A89
12345